All
Tecentriq Improves Survival in Trial of Subset of Patients With Advanced Lung Cancer
September 2nd 2016According to recent findings from a phase 3 trial, the immunotherapy Tecentriq (atezolizumab) improved survival compared with docetaxel in patients with advanced non–small cell lung cancer (NSCLC) following the failure of platinum-based chemotherapy.
Study Confirms Accuracy for Test to Guide Early Breast Cancer Treatment
September 2nd 2016Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.
Need for Improvement: Colorectal Cancer Screening Among Hispanic Men
September 2nd 2016Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for Hispanic men, rates have remained essentially unchanged. A new study suggests that lower rates of screening may be the driver of this disparity.